Cargando…
Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants
New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are continuing to spread globally, contributing to the persistence of the COVID-19 pandemic. Increasing resources have been focused on developing vaccines and therapeutics that target the Spike glycoprotein of SARS-CoV-2. R...
Autores principales: | Satta, Sandro, Shahabipour, Fahimeh, Gao, Wei, Lentz, Steven R., Perlman, Stanley, Ashammakhi, Nureddin, Hsiai, Tzung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254234/ https://www.ncbi.nlm.nih.gov/pubmed/35832078 http://dx.doi.org/10.7150/thno.72339 |
Ejemplares similares
-
Engineering organ-on-a-chip systems to model viral infections
por: Shahabipour, Fahimeh, et al.
Publicado: (2023) -
An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages
por: Satta, Sandro, et al.
Publicado: (2022) -
Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19)
por: Ertas, Yavuz Nuri, et al.
Publicado: (2021) -
Rapid Detection and Inhibition of SARS‐CoV‐2‐Spike Mutation‐Mediated Microthrombosis
por: Satta, Sandro, et al.
Publicado: (2021) -
Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19
por: Satta, Sandro, et al.
Publicado: (2023)